3 Recruiting Metastatic Lung Non-Small Cell Carcinoma Clinical Trials in Ohio
Explore active metastatic lung non-small cell carcinoma research studies enrolling across Ohio. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Metastatic Lung Non-Small Cell Carcinoma Studies in Ohio
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔